CCDC80 |
DOWN |
rat epithelial cells neoplastically transformed by β-catenin. |
|
[9] |
|
CCDC80 |
DOWN |
thyroid neoplastic cell lines and tissues |
|
[14] |
|
CCDC80 |
DOWN |
colon and pancreatic cancer cells. |
mediates growth inhibition |
[9] |
|
SRPX |
DOWN |
highly malignant human pulmonary neuroendocrine tumors. |
|
[10] |
|
SRPX |
DOWN |
prostate carcinomas. |
|
[89] |
|
SRPX |
DOWN |
colorectal neoplasms. |
|
[90] |
|
SRPX |
DOWN |
lung adenocarcinomas. |
|
[91] |
|
SRPX |
DOWN |
colon adenocarcinomas. |
|
[92] |
|
SRPX |
DOWN |
endothelial cells, myeloma |
|
[93] |
|
SRPX |
DOWN |
stromal fibroblast cells from liver metastases of colorectal cancer |
|
[94] |
|
SRPX |
NA |
SRPX knock-out mouse embryonic fibroblasts |
involvement in the maturation process of autophagy |
[13] |
|
SRPX |
NA |
malignant tumors including lymphomas, lung adenocarcinomas and hepatomas |
Tumors appear in SRPX-knock out mice |
[11] |
|
SRPX |
NA |
human cancer cell lines. |
apoptosis induction in human cancer cell lines; both the P-DUDES and the sushi regions necessary |
[12] |
|
SRPX2 |
NA |
endothelial cells |
mediator of angiogenesis |
[20] |
|
SRPX2 |
NA |
|
ligand for uPAR |
[19] |
|
SRPX2 |
UP |
gastric cancer |
enhancing cellular migration and adhesion through FAK signaling |
[16,17] |
|
SRPX2 |
UP |
pro-B leukemia cells |
|
[5] |